Lv1
18 积分 2025-12-04 加入
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents
2个月前
已完结
BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia
3个月前
已完结
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
6个月前
已完结
Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML
6个月前
已完结
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
6个月前
已完结
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
6个月前
已完结
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia
6个月前
已完结
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
6个月前
已完结
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
7个月前
已完结
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
7个月前
已完结